Huyang Xie

No.20 West Temple Road
Nantong, 226001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Diagnostic efficacy of circulating tumor cell in clinically significant prostate cancer.

Diagnostic efficacy of circulating tumor cell in clinically significant prostate cancer.

Journal: Scientific reports
Published: February 15, 2026

Mendelian Randomization Identified SLC2A9 as a Novel cis-eQTL-Mediated Susceptibility Gene in Suppressing Renal Cancer and Its Related Metabolic Mechanisms.

Mendelian Randomization Identified SLC2A9 as a Novel cis-eQTL-Mediated Susceptibility Gene in Suppressing Renal Cancer and Its Related Metabolic Mechanisms.

Journal: Mediators of inflammation
Published: March 12, 2025

Predictive value of inflammatory marker PLR in prostate cancer.

Predictive value of inflammatory marker PLR in prostate cancer.

Journal: BMC urology
Published: May 20, 2024

Erratum to "Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion" [Eur. Urol. 75(5) (2019) 752-763].

Erratum to "Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion" [Eur. Urol. 75(5) (2019) 752-763].

Journal: European urology
Published: September 25, 2023

Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencing.

Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencing.

Journal: BMC urology
Published: May 21, 2023

Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma.

Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma.

Journal: European journal of immunology
Published: July 29, 2022

Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer.

Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer.

Journal: Frontiers in oncology
Published: April 17, 2019

Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer.

Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer.

Journal: Cancer research
Published: December 10, 2018

MiR-455-5p Suppresses the Progression of Prostate Cancer by Targeting CCR5.

MiR-455-5p Suppresses the Progression of Prostate Cancer by Targeting CCR5.

Journal: BioMed research international
Published: November 22, 2018

Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.

Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.

Journal: European urology
Published: June 08, 2018

Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma.

Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma.

Journal: Scientific reports
Published: April 14, 2018

circLPAR1 is a novel biomarker of prognosis for muscle-invasive bladder cancer with invasion and metastasis by miR-762.

circLPAR1 is a novel biomarker of prognosis for muscle-invasive bladder cancer with invasion and metastasis by miR-762.

Journal: Oncology letters
Published: February 01, 2018
Showing 1-12 of 26

Last Updated: 09/26/2026